Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA)

Permanent

The Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) is a global drug discovery and development program focused on supporting academic scientists in defining optimal strategies for advancing new, cutting-edge therapeutics from the lab to patients.